Clinical Trial Update: Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit [EARLY_Phase 1]

View source ↗

Summary

An early-phase evaluation of the Vascudyne Coronary Artery Bypass Conduit for coronary artery disease, with the trial currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Vascudyne Coronary Artery Bypass Conduit

Snippet

Sponsor: Vascudyne, Inc. | Conditions: Coronary Artery Disease | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION